EVT801
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EVT801, covering 2025-09-02 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours [Phase 1]